Comparative dynamics of four smoking withdrawal symptom scales.

AIMS   To examine the association of person-specific trajectories of withdrawal symptoms of urge-to-smoke, negative affect, physical symptoms and hunger during the first 7 days after smoking cessation with abstinence at end of treatment (EOT) and at 6 months. DESIGN   Hierarchical linear modeling (HLM) was used to model person-specific trajectory parameters (level, slope, curvature and volatility) for withdrawal symptoms. SETTING   University-based smoking cessation trials. PARTICIPANTS   Treatment-seeking smokers in clinical trials of transdermal nicotine versus nicotine spray (n = 514) and bupropion versus placebo (n = 421). MEASUREMENTS   Self-reported withdrawal symptoms for 7 days after the planned quit date, and 7-day point prevalence and continuous abstinence at EOT and 6 months. FINDINGS   In regressions that included trajectory parameters for one group of withdrawal symptoms, both urge-to-smoke and negative affect were predictive of abstinence while physical symptoms and hunger were generally not predictive. In stepwise regressions that included the complete set of trajectory parameters across withdrawal symptoms (for urge-to-smoke, negative affect, physical symptoms and hunger), with a single exception only the trajectory parameters for urge-to-smoke were predictive. Area under the receiver operator characteristic curve was 0.594 for covariates alone, and 0.670 for covariates plus urge-to-smoke trajectory parameters. CONCLUSIONS   Among a number of different withdrawal symptoms (urge-to-smoke, negative affect, physical symptoms and hunger) urge-to-smoke trajectory parameters (level, slope and volatility) over the first 7 days of smoking cessation show the strongest prediction of both short- and long-term relapse. Other withdrawal symptoms increase the predictive ability by negligible amounts.

[1]  M. Fiore,et al.  Smoking withdrawal dynamics in unaided quitters. , 2000, Journal of abnormal psychology.

[2]  H. Javitz,et al.  The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy. , 2011, Addiction.

[3]  Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers. , 2003 .

[4]  S. Shiffman,et al.  The relevance and treatment of cue-induced cravings in tobacco dependence. , 2009, Journal of substance abuse treatment.

[5]  D. Conti,et al.  Nicotinic acetylcholine receptor β2 subunit gene implicated in a systems-based candidate gene study of smoking cessation , 2008, Human molecular genetics.

[6]  K. Conneely,et al.  The Galanin Receptor 1 Gene Associates with Tobacco Craving in Smokers Seeking Cessation Treatment , 2011, Neuropsychopharmacology.

[7]  Timothy B Baker,et al.  Life before and after quitting smoking: an electronic diary study. , 2006, Journal of abnormal psychology.

[8]  L. Epstein,et al.  Role of Functional Genetic Variation in the Dopamine D2 Receptor (DRD2) in Response to Bupropion and Nicotine Replacement Therapy for Tobacco Dependence: Results of Two Randomized Clinical Trials , 2006, Neuropsychopharmacology.

[9]  S Shiffman,et al.  A day at a time: predicting smoking lapse from daily urge. , 1997, Journal of abnormal psychology.

[10]  J. Cappelleri,et al.  Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale , 2005, Current medical research and opinion.

[11]  M. Fiore,et al.  Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity. , 2003, Experimental and clinical psychopharmacology.

[12]  H. Aubin,et al.  Craving's place in addiction theory: Contributions of the major models , 2010, Neuroscience & Biobehavioral Reviews.

[13]  L. Epstein,et al.  Toward Personalized Therapy for Smoking Cessation: A Randomized Placebo‐controlled Trial of Bupropion , 2008, Clinical pharmacology and therapeutics.

[14]  Megan E. Piper,et al.  Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes. , 2009, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[15]  Megan E. Piper,et al.  Tobacco withdrawal components and their relations with cessation success , 2011, Psychopharmacology.

[16]  C. Lerman,et al.  Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation , 2006, Clinical pharmacology and therapeutics.

[17]  Thomas R. Kirchner,et al.  Cigarette-by-cigarette satisfaction during ad libitum smoking. , 2009, Journal of abnormal psychology.

[18]  J. Etter,et al.  A comparison of the psychometric properties of three cigarette withdrawal scales. , 2006, Addiction.

[19]  Thomas H. Brandon,et al.  The early time course of smoking withdrawal effects , 2006, Psychopharmacology.

[20]  Yantao Zuo,et al.  Neurotransmission-related genetic polymorphisms, negative affectivity traits, and gender predict tobacco abstinence symptoms across 44 days with and without nicotine patch. , 2009, Journal of abnormal psychology.

[21]  S S Smith,et al.  Development and validation of the Wisconsin Smoking Withdrawal Scale. , 1999, Experimental and clinical psychopharmacology.

[22]  Christina N. Lessov-Schlaggar,et al.  Association of tobacco dependence and quit attempt duration with Rasch-modeled withdrawal sensitivity using retrospective measures. , 2009, Addiction.

[23]  Megan E. Piper,et al.  Addiction motivation reformulated: an affective processing model of negative reinforcement. , 2004, Psychological review.

[24]  J. Hughes,et al.  Effects of abstinence from tobacco: valid symptoms and time course. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[25]  Timothy B Baker,et al.  Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations. , 2003, Journal of abnormal psychology.